VistaGen Therapeutics Inc. (NASDAQ: VTGN)
$3.87
-0.0450 ( -1.15% ) 34.2K
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Market Data
Open
$3.87
Previous close
$3.91
Volume
34.2K
Market cap
$104.45M
Day range
$3.81 - $3.95
52 week range
$1.63 - $24.71
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Jan 03, 2024 |
| 8-k | 8K-related | 15 | Nov 09, 2023 |
| 10-q | Quarterly Reports | 48 | Nov 09, 2023 |
| 8-k/a | 8K-related | 13 | Nov 07, 2023 |
| 8-k | 8K-related | 13 | Nov 06, 2023 |
| 3 | Insider transactions | 2 | Nov 03, 2023 |
| 8-k | 8K-related | 14 | Oct 26, 2023 |
| 4 | Insider transactions | 1 | Oct 06, 2023 |
| 8-k | 8K-related | 86 | Oct 04, 2023 |
| 8-k | 8K-related | 13 | Oct 02, 2023 |